The finding that hypertension and higher BMI positively contribute to predicting GLP-1 M responsiveness is consistent with the current approach of using GLP-1 M for protection of the cardiovascular system and promoting weight loss [3]. The gene discussed is GCG; the disease is hypertensive disorder.